Literature DB >> 6743473

Reduced elimination of ketoprofen in the elderly is not necessarily due to impaired glucuronidation.

R K Verbeeck, S M Wallace, G R Loewen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6743473      PMCID： PMC1463419          DOI： 10.1111/j.1365-2125.1984.tb02421.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  11 in total

1.  Measurement of clofibric acid (CPIB) metabolites in plasma of patients on clofibrate therapy.

Authors:  E M Faed; E G McQueen
Journal:  Clin Exp Pharmacol Physiol       Date:  1979 May-Jun       Impact factor: 2.557

2.  Clofibrate disposition in renal failure and acute and chronic liver disease.

Authors:  R Gugler; J W Kürten; C J Jensen; U Klehr; J Hartlapp
Journal:  Eur J Clin Pharmacol       Date:  1979-06-12       Impact factor: 2.953

3.  Physiological disposition of fenoprofen in man. 3. Metabolism and protein binding of fenoprofen.

Authors:  A Rubin; P Warrick; R L Wolen; S M Chernish; A S Ridolfo; C M Gruber
Journal:  J Pharmacol Exp Ther       Date:  1972-11       Impact factor: 4.030

Review 4.  Glucuronidation and disposition of drug glucuronides in patients with renal failure. A review.

Authors:  R K Verbeeck
Journal:  Drug Metab Dispos       Date:  1982 Jan-Feb       Impact factor: 3.922

5.  Pharmacokinetics of ketoprofen in the elderly.

Authors:  C Advenier; A Roux; C Gobert; P Massias; O Varoquaux; B Flouvat
Journal:  Br J Clin Pharmacol       Date:  1983-07       Impact factor: 4.335

6.  Biotransformation of diflunisal and renal excretion of its glucuronides in renal insufficiency.

Authors:  R Verbeeck; T B Tjandramaga; A Mullie; R Verbesselt; R Verberckmoes; P J de Schepper
Journal:  Br J Clin Pharmacol       Date:  1979-03       Impact factor: 4.335

7.  Negligible excretion of unchanged ketoprofen, naproxen, and probenecid in urine.

Authors:  R A Upton; J N Buskin; R L Williams; N H Holford; S Riegelman
Journal:  J Pharm Sci       Date:  1980-11       Impact factor: 3.534

8.  Probenecid-clofibrate interaction.

Authors:  J R Veenendaal; P M Brooks; P J Meffin
Journal:  Clin Pharmacol Ther       Date:  1981-03       Impact factor: 6.875

9.  Pharmacokinetics of ketoprofen in patients with chronic renal failure.

Authors:  G Stafanger; H W Larsen; H Hansen
Journal:  Scand J Rheumatol       Date:  1981       Impact factor: 3.641

10.  Effects of probenecid on ketoprofen kinetics.

Authors:  R A Upton; R L Williams; J N Buskin; R M Jones
Journal:  Clin Pharmacol Ther       Date:  1982-06       Impact factor: 6.875
View more
  10 in total

Review 1.  The pharmacokinetics of non-steroidal anti-inflammatory drugs in the elderly.

Authors:  K W Woodhouse; H Wynne
Journal:  Clin Pharmacokinet       Date:  1987-02       Impact factor: 6.447

Review 2.  Nonsteroidal anti-inflammatory drugs. Differential use in older patients.

Authors:  L Girgis; P Brooks
Journal:  Drugs Aging       Date:  1994-02       Impact factor: 3.923

3.  Pharmacokinetic profile of controlled release ketoprofen in elderly patients.

Authors:  M J Dennis; P C French; P Crome; M Babiker; J Shillingford; R Hopkins
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

4.  Pharmacokinetics of ketoprofen enantiomers in cholecystectomy patients: influence of probenecid.

Authors:  R T Foster; F Jamali; A S Russell
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 5.  Clinical pharmacokinetics of ketoprofen and its enantiomers.

Authors:  F Jamali; D R Brocks
Journal:  Clin Pharmacokinet       Date:  1990-09       Impact factor: 6.447

6.  Pharmacokinetics and tolerance of romazarit after oral administration of ascending single doses to healthy human volunteers.

Authors:  P E Williams; G J Muirhead; E Worth; R Zimmer; P Lücker
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Oct-Dec       Impact factor: 2.441

Review 7.  The problems and pitfalls of NSAID therapy in the elderly (Part II).

Authors:  A G Johnson; R O Day
Journal:  Drugs Aging       Date:  1991-05       Impact factor: 3.923

Review 8.  Adverse drug interactions with nonsteroidal anti-inflammatory drugs (NSAIDs). Recognition, management and avoidance.

Authors:  A G Johnson; P Seideman; R O Day
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606

Review 9.  Clinical pharmacokinetics of ketorolac tromethamine.

Authors:  D R Brocks; F Jamali
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

Review 10.  Clinical pharmacokinetic considerations in the elderly. An update.

Authors:  S Dawling; P Crome
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.